Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Treasury Shares (2020 - 2025)

BioAtla's Treasury Shares history spans 6 years, with the latest figure at $2.4 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 56.72% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $2.4 million, up 56.72%, while the annual FY2025 figure was $2.4 million, 56.72% up from the prior year.
  • Treasury Shares reached $2.4 million in Q4 2025 per BCAB's latest filing, down from $2.5 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.9 million in Q1 2025 to a low of $99104.0 in Q4 2023.
  • Average Treasury Shares over 5 years is $1.3 million, with a median of $1.6 million recorded in 2024.
  • Peak YoY movement for Treasury Shares: tumbled 80.57% in 2023, then surged 1467.04% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $975046.0 in 2021, then plummeted by 47.69% to $510039.0 in 2022, then crashed by 80.57% to $99104.0 in 2023, then soared by 1467.04% to $1.6 million in 2024, then skyrocketed by 56.72% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Treasury Shares are $2.4 million (Q4 2025), $2.5 million (Q3 2025), and $2.6 million (Q2 2025).